T. Rowe Price Investment Management, Inc.
Position in STTK — Shattuck Labs, Inc.
CIK 1897612
BALTIMORE, MD
Position in STTK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$63,436
+$58,491 QoQ
Shares Held
9,865,558
+628.2% QoQ
Ownership
12.9%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026T. Rowe Price Investment Management, Inc. holds $10,766,161 across 48 Biotechnology names. STTK ranks #22 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,193,324 | $1,718,316 | |
| 2 | ASND |
Ascendis Pharma A/S
|
6,162,042 | $1,409,444 | |
| 3 | CYTK |
Cytokinetics Inc
|
17,523,840 | $1,154,997 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
10,300,984 | $867,034 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
12,126,017 | $704,643 | |
| 6 | DYN |
Dyne Therapeutics, Inc.
|
30,785,801 | $558,147 | |
| 7 | BNTX |
BioNTech SE
|
5,856,073 | $520,488 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
6,159,027 | $462,482 |
All Filings in STTK
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $63,436 | 9,865,558 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,945 | 1,354,761 | Shares | Sole | 2026-02-19 | |
| No filing history on record for this holder in this stock. | ||||||